Provided by Tiger Trade Technology Pte. Ltd.

LandBridge Co. LLC

87.46
+1.742.03%
Volume:245.20K
Turnover:21.47M
Market Cap:6.74B
PE:77.40
High:88.99
Open:85.98
Low:85.98
Close:85.72
52wk High:91.69
52wk Low:43.75
Shares:77.09M
Float Shares:28.15M
Volume Ratio:1.12
T/O Rate:0.87%
Dividend:0.46
Dividend Rate:0.53%
EPS(TTM):1.13
EPS(LYR):0.9358
ROE:11.52%
ROA:7.07%
PB:18.96
PE(LYR):93.46

Loading ...

How Investors Are Reacting To LandBridge Stock 100 Million Senior Notes Offering

Simply Wall St.
·
Oct 06

LandBridge Updates Financial Calendar with Third-Quarter Earnings Release and Conference Call

Reuters
·
Oct 06

LandBridge Unit DBR Land Holdings Prices Additional USD 125 Million 6.25% Senior Notes Due 2030

Reuters
·
Oct 02

LandBridge Shareholders Back Conversion, Redomiciling to Texas as LandBridge Corp

Reuters
·
Sep 23

Landbridge Announces Pricing of Upsized $125,000,000 Offering of Additional 6.250% Senior Notes Due 2030

THOMSON REUTERS
·
Sep 23

LandBridge Plans USD 100 Million Senior Notes Offering

Reuters
·
Sep 22

LandBridge Price Target Raised to $88.00/Share from $80.00 by Piper Sandler

Dow Jones
·
Sep 02

LB Group's H1 Profit Drops 39%

MT Newswires Live
·
Aug 27

LandBridge Price Target Raised to $86.00/Share from $66.00 by Citigroup

Dow Jones
·
Aug 26

LandBridge price target raised to $86 from $66 at Citi

TIPRANKS
·
Aug 26

LB Pharmaceuticals price target raised to $69 from $45 at Clear Street

TIPRANKS
·
Aug 21

LandBridge Files Draft Information Statement for Shareholders

Reuters
·
Aug 19

S&P 500 Futures Decline in Premarket Trading; Bio-Rad Labs A, Fabrinet Lag

Dow Jones
·
Aug 18

Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)

TIPRANKS
·
Aug 12

LandBridge Director, 10% Owner David N. Capobianco Reports Disposal of USD 93.81 Million in Common Shares

Reuters
·
Aug 12

LB Pharmaceuticals Q2 Loss Per Share Narrows

MT Newswires Live
·
Aug 11

Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, vs. FactSet Est of $0.81 Loss

MT Newswires Live
·
Aug 11

LB Pharmaceuticals Q2 EPS $(1.71) Misses $(0.80) Estimate

Benzinga Earnings
·
Aug 11

Press Release: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 11

LB Pharmaceuticals management to meet with Piper Sandler

TIPRANKS
·
Aug 11